The original name “BioCell Collagen II” made reference to one of the ingredient's integral component parts, type II collagen. The designation made sense during the early years of BioCell Collagen, mainly because of the strong association between type II collagen and joint health. However, as more studies were conducted on BioCell Collagen, the data repeatedly pointed in one direction; BioCell Collagen is much more than a joint health ingredient. The single-source, all-natural ingredient contains a naturally existing matrix of hydrolyzed collagen type II, hyaluronic acid, and chondroitin sulfate, all of which are highlybioavailable.
The completion of the first human skin study on BioCell Collagen was announced on June 23rd, 2011. The study suggested that BioCell Collagen stimulates dermal fibroblasts, which are responsible for skin collagen (primarily collagen types I and III) production. Armed with this knowledge, the BioCell Technology team felt that the name “BioCell Collagen II®” limited its perception in the marketplace and failed to elucidate the ingredient’s full breadth of multiple benefits. Therefore, removing the “II” from the name is both a practical change, as well as a symbolic gesture. It turns the page on the first chapter of BioCell Collagen, one in which the focus was purely related to joint health, into a new era of looking to the ingredient as the answer for comprehensive connective tissue health.
Dr. Joosang Park, VP of scientific affairs at the company, details the scientific rationale behind the rebranding of BioCell Collagen. “It was well established that hydrolyzed collagen type II, a key constituent of BioCell Collagen, stimulated the biosynthesis of collagen type II from the cartilage-building chondrocytes, raising a possibility of cartilage regeneration by the ingestion of hydrolyzed collagen. The recently completed human skin study on BioCell Collagen showed a significant increase in collagen content in the skin dermis. This and earlier studies demonstrate the unique biological properties of BioCell Collagen to support the dermal matrix containing collagen types I and III as well as the cartilage containing type II. These findings add to the portfolio of research that makes BioCell Collagen a highly-differentiated nutraceutical substantiated by multiple human studies.”
BioCell Collagen® also receives a new logo to go along with its rebrand. The main change to the logo is a brand new font, which is specifically designed to be easier to read on a product label. The logo still maintains a strong resemblance to its predecessor, and even with the aforementioned changes customers of BioCell Collagen will still be greeted with the familiar capsule shaped logo and distinctive blue and white color scheme. The new logo is available to be used on licensed product labels and marketing materials immediately.
About BioCell Collagen:
BioCell Collagen ® is an innovative dietary ingredient marketed as a healthy aging nutritional supplement that promotes both healthy joints and more youthful-looking skin. It is unique in that it is a naturally-occurring matrix whose three major constituents, collagen type II, chondroitin sulfate, and hyaluronic acid, are reduced to highly-bioavailable, very low molecular weight forms due to its patented hydrolysis process. Made exclusively from articular sternum cartilage, its composition is similar to that of human articular joint cartilage.
About BioCell Technology:
Founded in 1997, BioCell Technology, LLC is the exclusive supplier of BioCell Collagen II® and owns the exclusive rights to market it under US Patents 6,025,327, 6,323,319, 6,780,841 and 7,091,180. The product logo is registered and is available for display on the labels of BioCell Technology, LLC's private label clients for marketing under their own brand names or formulas. BioCell Technology is the recipient of the 2010-2011 Frost & Sullivan award for best practices. For more information on BioCell Collagen II, please contact BioCell Technology, LLC at (714) 632-1231 or visit www.biocelltechnology.com.